Tyrosinase (TYR) inhibition has become a recent target in Parkinson’s disease research [17], since TYR in excess amount (a copper-containing enzyme involved in the synthesis of melanin and neuromelanin formation) causes deterioration in functions of nigral neurons [18]. Here, TYR is linked to Parkinson disease.